Kendler DL, Roux C, Benhamou CL, et al. Effects of denosumab on bone mineral density, bone turnover in postmenopausal women transitioning from alendronate therapy. J Bone Miner Res. 2010, 25(1):72-81. doi: 10.1359/jbmr.090716.
Advertisement
Articles by Kendler DL, Roux C, Benhamou CL, et al. Effects of denosumab on bone mineral density, bone turnover in postmenopausal women transitioning from alendronate therapy. J Bone Miner Res. 2010, 25(1):72-81. doi: 10.1359/jbmr.090716.
Advertisement
Latest Updated Articles
- Study Summary: STAND
Published: August 9th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Inebilizumab for Generalized Myasthenia Gravis
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD
4
5 Key Oncology FDA Approvals From November
5
